294
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Applying Biopharmaceutical Classification System Criteria to Predict the Potential Effect of Cremophor® RH 40 on Fexofenadine Bioavailability at Higher Doses

ORCID Icon, ORCID Icon & ORCID Icon
Pages 447-464 | Received 18 Apr 2020, Accepted 10 Jul 2020, Published online: 26 Jul 2020

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.